(MedPage Today) — Treating early Alzheimer’s disease patients with lecanemab (Leqembi) was feasible and most patients tolerated the drug well, a retrospective study at one specialty memory clinic showed.
Infusion-related reactions occurred in…
Source link : https://www.medpagetoday.com/neurology/alzheimersdisease/115551
Author :
Publish date : 2025-05-12 20:22:00
Copyright for syndicated content belongs to the linked Source.
